title: Defining gene-phenotype relationships in Acinetobacter baumannii through one-step chromosomal gene inactivation.
abstract: Rates of infection with hospital-acquired Acinetobacter baumannii have exploded over the past decade due to our inability to limit persistence and effectively treat disease. A. baumannii quickly acquires antibiotic resistance, and its genome encodes mechanisms to tolerate biocides and desiccation, which enhance its persistence in hospital settings. With depleted antibiotic options, new methods to treat A. baumannii infections are desperately needed. A comprehensive understanding detailing A. baumannii cellular factors that contribute to its resiliency at genetic and mechanistic levels is vital to the development of new treatment options. Tools to rapidly dissect the A. baumannii genome will facilitate this goal by quickly advancing our understanding of A. baumannii gene-phenotype relationships. We describe here a recombination-mediated genetic engineering (recombineering) system for targeted genome editing of A. baumannii. We have demonstrated that this system can perform directed mutagenesis on wide-ranging genes and operons and is functional in various strains of A. baumannii, indicating its broad application. We utilized this system to investigate key gene-phenotype relationships in A. baumannii biology important to infection and persistence in hospitals, including oxidative stress protection, biocide resistance mechanisms, and biofilm formation. In addition, we have demonstrated that both the formation and movement of type IV pili play an important role in A. baumannii biofilm. Importance: Acinetobacter baumannii is the causative agent of hospital-acquired infections, including pneumonia and serious blood and wound infections. A. baumannii is an emerging pathogen and has become a threat to public health because it quickly develops antibiotic resistance, making treatment difficult or impossible. While the threat of A. baumannii is well recognized, our understanding of even its most basic biology lags behind. Analysis of A. baumannii cellular functions to identify potential targets for drug development has stalled due in part to laborious genetic techniques. Here we have pioneered a novel recombineering system that facilitates efficient genome editing in A. baumannii by single PCR products. This technology allows for rapid genome editing to quickly ascertain gene-phenotype relationships. To demonstrate the power of recombineering in dissecting A. baumannii biology, we use this system to establish key gene-phenotype relationships important to infection and persistence in hospitals, including oxidative stress protection, biocide resistance, and biofilm formation.
authors.affiliation: Department of Molecular Biosciences, University of Texas at Austin, Austin, Texas, USA.
authors.forename: Ashley T
authors.initials: AT
authors.lastname: Tucker
authors.affiliation: Department of Molecular Biosciences, University of Texas at Austin, Austin, Texas, USA.
authors.forename: Emily M
authors.initials: EM
authors.lastname: Nowicki
authors.affiliation: Department of Molecular Biosciences, University of Texas at Austin, Austin, Texas, USA.
authors.forename: Joseph M
authors.initials: JM
authors.lastname: Boll
authors.affiliation: Department of Molecular Biosciences, University of Texas at Austin, Austin, Texas, USA.
authors.forename: Gregory A
authors.initials: GA
authors.lastname: Knauf
authors.affiliation: Department of Molecular Biosciences, University of Texas at Austin, Austin, Texas, USA.
authors.forename: Nora C
authors.initials: NC
authors.lastname: Burdis
authors.forename: M Stephen
authors.initials: MS
authors.lastname: Trent
authors.affiliation: bwdavies@austin.utexas.edu.
authors.forename: Bryan W
authors.initials: BW
authors.lastname: Davies
mesh_terms: D040981:Acinetobacter baumannii / Q000187:drug effects* / Q000235:genetics*; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001426:Bacterial Proteins / Q000235:genetics; D018441:Biofilms / Q000187:drug effects; D002710:Chlorhexidine / Q000494:pharmacology; D002876:Chromosomes, Bacterial / Q000187:drug effects / Q000235:genetics*; D020868:Gene Silencing / Q000187:drug effects; D056726:Genetic Association Studies; D016680:Genome, Bacterial / Q000235:genetics*; D008826:Microbial Sensitivity Tests
chemical_list: D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D002710:Chlorhexidine
references.citation: Methods Mol Biol. 2000;132:365-86
references.pmid: 10547847
references.citation: Science. 2011 Nov 18;334(6058):982-6
references.pmid: 22096200
references.citation: Mol Microbiol. 2010 May;76(4):889-904
references.pmid: 20345659
references.citation: Proc Natl Acad Sci U S A. 2000 May 23;97(11):5978-83
references.pmid: 10811905
references.citation: Antimicrob Agents Chemother. 2008 Feb;52(2):557-62
references.pmid: 18086852
references.citation: Mol Microbiol. 1994 Jan;11(1):137-53
references.pmid: 7908398
references.citation: Arch Biochem Biophys. 2012 Sep 15;525(2):161-9
references.pmid: 22381957
references.citation: J Bacteriol. 2010 Feb;192(4):994-1010
references.pmid: 20008072
references.citation: Microbiol Mol Biol Rev. 2010 Jun;74(2):273-97
references.pmid: 20508250
references.citation: Appl Environ Microbiol. 2010 Aug;76(15):4960-8
references.pmid: 20543050
references.citation: Biophys J. 2011 Apr 6;100(7):1608-16
references.pmid: 21463573
references.citation: J Bacteriol. 1993 Sep;175(18):5934-44
references.pmid: 8104179
references.citation: Nat Protoc. 2008;3(2):163-75
references.pmid: 18274517
references.citation: Antimicrob Agents Chemother. 2001 Dec;45(12):3375-80
references.pmid: 11709311
references.citation: Annu Rev Microbiol. 2012;66:493-520
references.pmid: 22746331
references.citation: Genes Dev. 2007 Mar 1;21(5):601-14
references.pmid: 17344419
references.citation: Mol Microbiol. 1994 Sep;13(6):1079-91
references.pmid: 7854122
references.citation: Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1626-31
references.pmid: 18230724
references.citation: Front Microbiol. 2012 Apr 23;3:148
references.pmid: 22536199
references.citation: Infect Immun. 1999 Jul;67(7):3625-30
references.pmid: 10377148
references.citation: Mol Syst Biol. 2006;2:2006.0008
references.pmid: 16738554
references.citation: Proc Natl Acad Sci U S A. 1989 May;86(10):3484-8
references.pmid: 2471187
references.citation: Genome Announc. 2013 Nov 07;1(6):
references.pmid: 24201195
references.citation: Science. 2011 Nov 18;334(6058):986-90
references.pmid: 22096201
references.citation: J Hosp Infect. 2012 Jan;80(1):56-60
references.pmid: 21975219
references.citation: Antimicrob Agents Chemother. 2007 Oct;51(10):3471-84
references.pmid: 17646423
references.citation: Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6640-5
references.pmid: 10829079
references.citation: J Bacteriol. 2003 Apr;185(7):2374-8
references.pmid: 12644510
references.citation: mBio. 2013 Aug 06;4(4):
references.pmid: 23919995
references.citation: BMC Microbiol. 2010 Nov 09;10:279
references.pmid: 21062436
references.citation: Nat New Biol. 1971 Jan 6;229(1):13-6
references.pmid: 5276049
references.citation: Future Microbiol. 2009 Apr;4(3):273-8
references.pmid: 19327114
references.citation: Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20254-9
references.pmid: 24277845
references.citation: J Mol Biol. 1998 Mar 6;276(4):721-31
references.pmid: 9500924
references.citation: Infect Control Hosp Epidemiol. 2014 Apr;35(4):406-11
references.pmid: 24602946
references.citation: Folia Histochem Cytobiol. 2008;46(3):257-67
references.pmid: 19056528
references.citation: Gene. 1998 May 28;212(1):77-86
references.pmid: 9661666
references.citation: J Infect Dis. 2008 Apr 15;197(8):1079-81
references.pmid: 18419525
references.citation: PLoS Genet. 2006 Jan;2(1):e7
references.pmid: 16415984